Celltrion, Stock Price Down 2.55% at This Time... 94,097 Shares Net Sold by Individuals in the Last 5 Days

As of 11:30 AM on the 12th, Celltrion is trading at 306,000 KRW, down 2.55% from the previous day. The trading volume is 579,837 shares, which is about 85.29% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On August 10, Jin Heung-guk, a researcher at Korea Investment & Securities, stated, "Following Remsima SC, the company plans to launch one or two new products annually, and its market position remains solid, strengthening its long-term growth potential. The company is making various efforts to break away from its biosimilar-focused business structure, including recent developments in COVID-19 therapeutics and the acquisition of Takeda Pharmaceutical's primary care business. In 2023, it plans to expand its third plant, doubling its annual production capacity compared to the current level. It is securing long-term growth potential along with profitability improvement." He set Celltrion's target price at 360,000 KRW.

Over the past five days, individual investors have net sold 94,097 shares of Celltrion, while foreigners and institutions have net sold 11,537 shares and net bought 91,148 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.